Viemed Healthcare, Inc. carries a market capitalization of 451.22M, placing it among publicly traded companies globally. Its enterprise value stands at 360.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 451.22M |
| Enterprise Value | 360.58M |
Viemed Healthcare, Inc. currently has 38.53M shares outstanding.
| Shares Outstanding | 38.53M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Viemed Healthcare, Inc. trades at a trailing price-to-earnings ratio of 23.90. The price-to-sales ratio is 1.24, and the price-to-book ratio stands at 2.82.
| PE Ratio | 23.90 |
| PS Ratio | 1.24 |
| PB Ratio | 2.82 |
| P/TBV Ratio | 4.16 |
| P/FCF Ratio | 4.23 |
| P/OCF Ratio | 6.23 |
On an enterprise value basis, Viemed Healthcare, Inc. trades at an EV/EBITDA multiple of 6.74 and an EV/FCF ratio of 4.04. The EV/Sales ratio of 1.26 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.09 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.26 |
| EV / EBITDA | 6.74 |
| EV / EBIT | 15.09 |
| EV / FCF | 4.04 |
Viemed Healthcare, Inc. maintains a current ratio of 1.22, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 8.53, indicating elevated leverage, while an interest coverage ratio of 45.50 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.22 |
| Quick Ratio | 1.01 |
| Debt / Equity | 8.53 |
| Debt / EBITDA | 0.23 |
| Interest Coverage | 45.50 |
Viemed Healthcare, Inc. posts a return on equity of 12.15 and a return on invested capital of 10.92.
| Return on Equity (ROE) | 12.15 |
| Return on Assets (ROA) | 7.93 |
| Return on Invested Capital (ROIC) | 10.92 |
| Return on Capital Employed (ROCE) | 11.35 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 25.08 |
Over the trailing twelve months, Viemed Healthcare, Inc. has paid 6.72M in income taxes, reflecting an effective tax rate of 30.40.
| Income Tax | 6.72M |
| Effective Tax Rate | 30.40 |
Viemed Healthcare, Inc.'s stock has gained approximately 92.32026% over the past 52 weeks. The 50-day moving average sits at 10.82, while the 200-day moving average is 8.68.
| Beta (5Y) | N/A |
| 52-Week Price Change | 92.32026% |
| 50-Day Moving Average | 10.82 |
| 200-Day Moving Average | 8.68 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Viemed Healthcare, Inc. generated 286.57M in revenue and converted that into 14.89M in net income, yielding earnings per share of 0.38. EBITDA reached 53.51M, while operating income came in at 23.89M.
| Revenue | 286.57M |
| Gross Profit | 165.01M |
| Operating Income | 23.89M |
| Pretax Income | 22.10M |
| Net Income | 14.89M |
| EBITDA | 53.51M |
| EBIT | 23.89M |
| Earnings Per Share (EPS) | 0.38 |
Viemed Healthcare, Inc. holds 9.76M in cash and equivalents against 12.44M in total debt, resulting in a net debt position of -557,000.00. Total book value stands at 126.28M, with working capital of 9.11M providing operational flexibility.
| Cash & Cash Equivalents | 9.76M |
| Total Debt | 12.44M |
| Net Debt | -557,000.00 |
| Equity (Book Value) | 126.28M |
| Book Value Per Share | 3.27 |
| Working Capital | 9.11M |
Viemed Healthcare, Inc. produced 57.13M in operating cash flow over the past twelve months. After subtracting -31.21M in capital expenditures, free cash flow totaled 25.92M - equivalent to 0.67 per share.
| Operating Cash Flow | 57.13M |
| Capital Expenditures | -31.21M |
| Free Cash Flow | 25.92M |
| FCF Per Share | 0.67 |
Viemed Healthcare, Inc. operates with a gross margin of 57.58, reflecting its pricing power and cost economics. The operating margin of 8.34 and net profit margin of 5.20 provide insight into operational efficiency.
| Gross Margin | 57.58 |
| Operating Margin | 8.34 |
| Pretax Margin | 7.71 |
| Profit Margin | 5.20 |
| EBITDA Margin | 18.67 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 2.92 |
| FCF Yield | 23.65 |
Viemed Healthcare, Inc. posts an Altman Z-Score of 7.96, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.96 |